Obesity medications linked to reduced chance of MS in real world
The use of obesity medications ā approved drugs for treating diabetes and promoting weight loss ā is associated with a reduced chance of developing multiple sclerosis (MS), according to real-world data from the U.S. Food and Drug Administration (FDA), a study found. In particular, medicines that activate a receptor…